Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548517 · ClinicalTrials.gov registry record · NA
TRE: Microbiome, Metabolic Health and Bone
A NA study of Weight Loss and Bone Loss, sponsored by Rutgers, The State University of New Jersey.
- Active
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05548517: Active NA study of Weight Loss and Bone Loss, sponsored by Rutgers, The State University of New Jersey.
NCT05548517 is a NA study of Weight Loss and Bone Loss that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 48 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05548517, a NA study of Weight Loss and Bone Loss, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.
Primary Outcome
dual energy x-ray absorptiometry
Conditions Studied
Interventions
- BEHAVIORAL Calorie Restriction
- BEHAVIORAL Time Restricted Eating (TRE)
Study Locations (1)
New Jersey
- Rutgers University - NJ Inst Food Nutrition & Health - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-10-15 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
What the registry record for NCT05548517 still lists
NCT05548517 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Calorie Restriction is the first listed.
NCT05548517 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05548517 about?
NCT05548517 is a clinical study titled "TRE: Microbiome, Metabolic Health and Bone". In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.
What is the current status of trial NCT05548517?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2022-10-15. Estimated completion is 2025-07-01.
What conditions does trial NCT05548517 study?
This clinical trial studies the following conditions: Weight Loss, Bone Loss, Time Restricted Feeding.
What interventions are being tested in trial NCT05548517?
The interventions under investigation include: Calorie Restriction (BEHAVIORAL), Time Restricted Eating (TRE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05548517?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548517 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05548517's enrollment target sits among peer trials
48 79th of 116 higher than 37 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI